scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0014-5793(97)00311-6 |
P698 | PubMed publication ID | 9141485 |
P2093 | author name string | Han L | |
Hermonat PL | |||
Quirk JG | |||
Bishop BM | |||
P2860 | cites work | Site-specific integration by adeno-associated virus | Q24558738 |
Adeno-associated virus (AAV) Rep proteins mediate complex formation between AAV DNA and its integration site in human DNA | Q24562760 | ||
Detection of specific sequences among DNA fragments separated by gel electrophoresis | Q25939003 | ||
Selective extraction of polyoma DNA from infected mouse cell cultures | Q29547500 | ||
Integration of the adeno-associated virus genome into cellular DNA in latently infected human Detroit 6 cells | Q33914608 | ||
Isolation of a lentivirus from a macaque with lymphoma: comparison with HTLV-III/LAV and other lentiviruses. | Q33927613 | ||
DNA synthesis and topoisomerase inhibitors increase transduction by adeno-associated virus vectors | Q34251868 | ||
Site-specific integration by adeno-associated virus is directed by a cellular DNA sequence | Q35829692 | ||
Targeted integration of adeno-associated virus (AAV) into human chromosome 19 | Q35936149 | ||
Cloning of adeno-associated virus into pBR322: rescue of intact virus from the recombinant plasmid in human cells | Q36288360 | ||
Adeno-associated virus vector for high-frequency integration, expression, and rescue of genes in mammalian cells | Q36425596 | ||
Adeno-associated virus general transduction vectors: analysis of proviral structures | Q36868692 | ||
Genetics of adeno-associated virus: isolation and preliminary characterization of adeno-associated virus type 2 mutants | Q36893013 | ||
Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells | Q37573696 | ||
Adeno-associated virus: a vector system for efficient introduction and integration of DNA into a variety of mammalian cell types | Q40660263 | ||
High-efficiency transfer of the T cell co-stimulatory molecule B7-2 to lymphoid cells using high-titer recombinant adeno-associated virus vectors | Q41263327 | ||
High prevalence of adeno-associated virus (AAV) type 2 rep DNA in cervical materials: AAV may be sexually transmitted | Q45767111 | ||
The regulatory rep protein of adeno-associated virus binds to sequences within the c-H-ras promoter | Q45782486 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | gene therapy | Q213901 |
vector-borne disease | Q2083837 | ||
P304 | page(s) | 78-84 | |
P577 | publication date | 1997-04-01 | |
P1433 | published in | FEBS Letters | Q1388051 |
P1476 | title | The packaging capacity of adeno-associated virus (AAV) and the potential for wild-type-plus AAV gene therapy vectors | |
P478 | volume | 407 |
Q34306694 | AAV2/8-hSMAD3 gene delivery attenuates aortic atherogenesis, enhances Th2 response without fibrosis, in LDLR-KO mice on high cholesterol diet |
Q36165834 | Adeno-associated virus vectors: potential applications for cancer gene therapy |
Q90259836 | Biomaterial-guided delivery of gene vectors for targeted articular cartilage repair |
Q33576852 | Characterization of genome integrity for oversized recombinant AAV vector |
Q33836499 | DNA as therapeutics; an update |
Q41093443 | Delivering Transgenic DNA Exceeding the Carrying Capacity of AAV Vectors |
Q40138075 | Development of In Vivo Imaging Tools for Investigating Astrocyte Activation in Epileptogenesis |
Q37591108 | Effective delivery of large genes to the retina by dual AAV vectors |
Q97527308 | Effects of Thermally Induced Configuration Changes on rAAV Genome's Enzymatic Accessibility |
Q42235082 | Efficient gene delivery to the cone-enriched pig retina by dual AAV vectors |
Q43983069 | Efficient generation of cytotoxic T lymphocytes against cervical cancer cells by adeno-associated virus/human papillomavirus type 16 E7 antigen gene transduction into dendritic cells |
Q45571369 | Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6. |
Q36601946 | Expressing Transgenes That Exceed the Packaging Capacity of Adeno-Associated Virus Capsids |
Q39576163 | Extending the transposable payload limit of Sleeping Beauty (SB) using the Herpes Simplex Virus (HSV)/SB amplicon-vector platform |
Q42270238 | Full-length dysferlin expression driven by engineered human dystrophic blood derived CD133+ stem cells |
Q34987213 | Gene delivery to the eye using adeno-associated viral vectors |
Q28086805 | Gene therapy for cancer: regulatory considerations for approval |
Q35943998 | Gene therapy for optic nerve disease |
Q55000684 | Guiding Lights in Genome Editing for Inherited Retinal Disorders: Implications for Gene and Cell Therapy. |
Q33729610 | Harnessing the Potential of Human Pluripotent Stem Cells and Gene Editing for the Treatment of Retinal Degeneration |
Q54981136 | High-throughput screening identifies kinase inhibitors that increase dual AAV vectors transduction in vitro and in mouse retina. |
Q27300915 | Homologous recombination mediates functional recovery of dysferlin deficiency following AAV5 gene transfer |
Q39639471 | Little vector, big gene transduction: fragmented genome reassembly of adeno-associated virus |
Q34586568 | Novel gene therapy viral vector using non-oncogenic lymphotropic herpesvirus |
Q37684186 | Optimization of AAV expression cassettes to improve packaging capacity and transgene expression in neurons |
Q33315726 | Optimized cDNA libraries for virus-induced gene silencing (VIGS) using tobacco rattle virus |
Q24533013 | Packaging capacity of adeno-associated virus serotypes: impact of larger genomes on infectivity and postentry steps |
Q34343763 | Proteasome inhibitors enhance gene delivery by AAV virus vectors expressing large genomes in hemophilia mouse and dog models: a strategy for broad clinical application |
Q45735544 | Quantitative comparison of expression with adeno-associated virus (AAV-2) brain-specific gene cassettes. |
Q45734168 | Rapid induction of cytotoxic T-cell response against cervical cancer cells by human papillomavirus type 16 E6 antigen gene delivery into human dendritic cells by an adeno-associated virus vector |
Q40933734 | Recombinant AAV-2 harboring gfp-antisense/ribozyme fusion sequences monitor transduction, gene expression, and show anti-HIV-1 efficacy |
Q34804660 | Self-complementary AAV vectors; advances and applications |
Q36545533 | Serotype-dependent packaging of large genes in adeno-associated viral vectors results in effective gene delivery in mice. |
Q26766232 | The therapeutic potential of genome editing for β-thalassemia |
Q36729692 | The use of recombinant adeno-associated virus for skeletal gene therapy |
Q47559127 | Triple Vectors Expand AAV Transfer Capacity in the Retina |
Search more.